ID

11698

Descripción

The study is designed to compare the efficacy and safety profile of cangrelor to standard of care in patients require percutaneous coronary intervention (PCI). (https://clinicaltrials.gov/ct2/show/NCT00097591)

Link

https://clinicaltrials.gov/ct2/show/NCT00097591

Palabras clave

Versiones (2)
  1. 28/7/15 28/7/15 -
  2. 20/11/15 20/11/15 -
Subido en

28 de julio de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Comparison of Prasugrel and Clopidogrel Acute Coronary Syndrome NCT00097591

Inglés

Eligibility Criteria

1 formularios  
  1. StudyEvent: ODM
    1. Eligibility Criteria
Inclusion Criteria
Descripción

Inclusion Criteria

Male or non-pregnant female
Descripción

Male or non-pregnant female

Tipo de datos

boolean

Alias
UMLS CUI-1
C0079399
non-pregnant female
Descripción

non-pregnant female

Tipo de datos

boolean

Alias
UMLS CUI-1
C0549206
at least 18 years of age
Descripción

at least 18 years of age

Tipo de datos

boolean

Alias
UMLS CUI-1
C0001779
Patients undergoing percutaneous coronary intervention (PCI)
Descripción

Patients undergoing percutaneous coronary intervention (PCI)

Tipo de datos

boolean

Alias
UMLS CUI-1
C1532338
Stable angina (SA) patients
Descripción

Stable angina (SA) patients

Tipo de datos

boolean

Alias
UMLS CUI-1
C0002962
with diagnostic coronary angiography
Descripción

with diagnostic coronary angiography

Tipo de datos

boolean

Alias
UMLS CUI-1
C0085532
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
Descripción

Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

Tipo de datos

boolean

Alias
UMLS CUI-1
C3537184
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
Descripción

Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis

Tipo de datos

boolean

Alias
UMLS CUI-1
C0948089
ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
Descripción

ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)

Tipo de datos

boolean

Alias
UMLS CUI-1
C1536220
Provide written informed consent
Descripción

Provide written informed consent

Tipo de datos

boolean

Alias
UMLS CUI-1
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
Descripción

Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization

Tipo de datos

boolean

Alias
UMLS CUI-1
C2936588
Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
Descripción

Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

Tipo de datos

boolean

Alias
UMLS CUI-1
C0253563
Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
Descripción

Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)

Tipo de datos

boolean

Alias
UMLS CUI-1
C0247025
Abciximab usage within 7 days preceding randomization
Descripción

Abciximab usage within 7 days preceding randomization

Tipo de datos

boolean

Alias
UMLS CUI-1
C0288672
Receipt of fibrinolytic therapy in the 12 hours preceding randomization
Descripción

Receipt of fibrinolytic therapy in the 12 hours preceding randomization

Tipo de datos

boolean

Alias
UMLS CUI-1
C0040044
Increased bleeding risk
Descripción

Increased bleeding risk

Tipo de datos

boolean

Alias
UMLS CUI-1
C3251812
ischemic stroke within the last year or any previous hemorrhagic stroke
Descripción

ischemic stroke within the last year or any previous hemorrhagic stroke

Tipo de datos

boolean

Alias
UMLS CUI-1
C0038454
tumor
Descripción

tumor

Tipo de datos

boolean

Alias
UMLS CUI-1
C0006826
cerebral arteriovenous malformation
Descripción

cerebral arteriovenous malformation

Tipo de datos

boolean

Alias
UMLS CUI-1
C0003857
intracranial aneurysm
Descripción

intracranial aneurysm

Tipo de datos

boolean

Alias
UMLS CUI-1
C0007766
recent (<1 month) trauma
Descripción

recent (<1 month) trauma

Tipo de datos

boolean

Alias
UMLS CUI-1
C3263723
major surgery (including bypass surgery)
Descripción

major surgery (including bypass surgery)

Tipo de datos

boolean

Alias
UMLS CUI-1
C0679637
currently receiving warfarin
Descripción

currently receiving warfarin

Tipo de datos

boolean

Alias
UMLS CUI-1
C0043031
active bleeding
Descripción

active bleeding

Tipo de datos

boolean

Alias
UMLS CUI-1
C0019080
Volver a la parte superior de la página

Similar models

Eligibility Criteria

1 formularios
  1. StudyEvent: ODM
    1. Eligibility Criteria
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion Criteria
Gender
Item
Male or non-pregnant female
boolean
C0079399 (UMLS CUI-1)
Pregnancy
Item
non-pregnant female
boolean
C0549206 (UMLS CUI-1)
Age
Item
at least 18 years of age
boolean
C0001779 (UMLS CUI-1)
PCI
Item
Patients undergoing percutaneous coronary intervention (PCI)
boolean
C1532338 (UMLS CUI-1)
Angina pectoris
Item
Stable angina (SA) patients
boolean
C0002962 (UMLS CUI-1)
Coronary angiography
Item
with diagnostic coronary angiography
boolean
C0085532 (UMLS CUI-1)
NSTEMI
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C3537184 (UMLS CUI-1)
Acute coronary syndrome
Item
Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) patients with diagnostic coronary angiography within 72 hours prior to randomization demonstrating atherosclerosis
boolean
C0948089 (UMLS CUI-1)
STEMI
Item
ST-segment elevation myocardial infarction (STEMI) patients (diagnostic angiography not required)
boolean
C1536220 (UMLS CUI-1)
Informed consent
Item
Provide written informed consent
boolean
C0021430 (UMLS CUI-1)
Item Group
Exclusion Criteria
Thienopyridines
Item
Receipt of any P2Y12 inhibitor at any time in the 7 days preceding randomization
boolean
C2936588 (UMLS CUI-1)
Eptifibatide
Item
Eptifibatide usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0253563 (UMLS CUI-1)
Tirofiban
Item
Tirofiban usage within 12 hours preceding randomization (most recent dose must have been administered ≥12 hours prior to randomization)
boolean
C0247025 (UMLS CUI-1)
Abciximab
Item
Abciximab usage within 7 days preceding randomization
boolean
C0288672 (UMLS CUI-1)
Thrombolytic Therapy
Item
Receipt of fibrinolytic therapy in the 12 hours preceding randomization
boolean
C0040044 (UMLS CUI-1)
Bleeding risk
Item
Increased bleeding risk
boolean
C3251812 (UMLS CUI-1)
Stroke
Item
ischemic stroke within the last year or any previous hemorrhagic stroke
boolean
C0038454 (UMLS CUI-1)
Tumor
Item
tumor
boolean
C0006826 (UMLS CUI-1)
Cerebral arteriovenous malformation
Item
cerebral arteriovenous malformation
boolean
C0003857 (UMLS CUI-1)
intracranial aneurysm
Item
intracranial aneurysm
boolean
C0007766 (UMLS CUI-1)
Trauma
Item
recent (<1 month) trauma
boolean
C3263723 (UMLS CUI-1)
Major surgery
Item
major surgery (including bypass surgery)
boolean
C0679637 (UMLS CUI-1)
Warfarin
Item
currently receiving warfarin
boolean
C0043031 (UMLS CUI-1)
Hemorrhage
Item
active bleeding
boolean
C0019080 (UMLS CUI-1)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial